Used in the synthesis of fluorinated pharmaceutical intermediates, particularly in the development of antifungal agents. Featuring an amino and hydroxymethyl group on a stereogenic carbon with a 2,6-difluorophenyl substituent, its structure supports the creation of chiral building blocks for bioactive molecules. Commonly employed in medicinal chemistry for optimizing drug potency and metabolic stability. Also utilized in asymmetric synthesis due to its stereogenic center, enabling the production of enantiomerically pure compounds.